Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
about
Urinary tract infection in the neurogenic bladderPractical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder SyndromeIn vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5.Current and potential urological applications of botulinum toxin A.Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.Urinary tract infections in multiple sclerosis.Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: A systematic review.Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxina or abobotulinumtoxina: A comparative study in the mice.A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity.Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
P2860
Q26767308-0143D814-85B9-424C-A892-1C4F7B4E6994Q26770415-3158A5EF-4199-4F9B-9929-626B5C33AC9BQ36315520-511F3F13-F0E7-451E-BF93-05A0E0671280Q38564108-38BAC55A-763E-4785-9432-07B70F5032D8Q38675157-40D3EF0B-9620-4873-B2D3-98ACAA125640Q38739811-F56D2949-9055-4C0A-8BCB-D5A355241F63Q38819016-017102D2-62FB-40D9-81C2-D16DDD996B65Q38836383-5A0A81F5-597A-4519-A8BA-CE19EBEB9491Q39196977-65B0FC67-66BD-47AB-ACE0-156DFF9B9B47Q40949732-0B8F64CF-DC92-432B-AFF2-2A667AE8E162Q42396665-EC5A1329-5963-489D-96C6-08D76EF61262Q48075632-75DFF41B-DB54-41B7-B753-CEF9F81A0C8AQ50890026-8701995D-962A-4E44-8EEC-8B67A2953EBA
P2860
Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@ast
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@en
type
label
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@ast
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@en
prefLabel
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@ast
Chapter 5: Clinical data in ne ...... and overactive bladder (OAB).
@en
P2860
P356
P1476
Chapter 5: Clinical data in ne ...... ) and overactive bladder (OAB)
@en
P2093
Victor Nitti
P2860
P304
P356
10.1002/NAU.22630
P478
33 Suppl 3
P577
2014-07-01T00:00:00Z